anonymous
Guest
anonymous
Guest
$17m in net revenue. Loss in Q3 of $159m. $100m of $500m left of funding.
that’s a bad gross to net. Need to ease up on the full buy down for Rx’s: not only is it expensive, you also have to pay fee to the agency that processes the copay discount. Gets very expensive.